Evidence map›Paper›PMID 40771968›Full record

ArticleFrontiers in neurology2025

Quantification of rehabilitation for patients with Parkinson's disease and related disorders using wearable devices; a proof of concept.

Hikaru Kamo, Genko Oyama, Koichi Nagaki, Nobutaka Hattori

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hikaru KamoDepartment of Neurology, Juntendo University School of Medicine, Bunkyo, Japan.
Genko OyamaDepartment of Neurology, Juntendo University School of Medicine, Bunkyo, Japan.
Koichi NagakiDepartment of Neurology, Juntendo University School of Medicine, Bunkyo, Japan.
Nobutaka HattoriDepartment of Neurology, Juntendo University School of Medicine, Bunkyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: To date, disease-modifying therapies have not been established for Parkinson's disease (PD) or atypical parkinsonisms. Exercise has been reported to help maintain functional abilities and delay disease progression. However, no consensus exists regarding the type, amount, or timing of exercise for each disease stage. Therefore, this study aimed to quantify rehabilitation interventions and identify optimal approaches based on patient characteristics. Methods: Participants diagnosed with PD or related disorders and residing in an elderly care facility received various rehabilitation therapies-including water stimulation bed, therapeutic massage, sit-to-stand training, gait training, cycle ergometer training, aerobic training using treadmill, stretching, balance training, calisthenics, and resistance training-while wearing a wearable device between April and May 2022. The following parameters were evaluated: differences in body surface temperature and pulse rate before and after rehabilitation, calories burned, steps taken during rehabilitation, and upper and lower extremity activity indices. Results: A total of 49 participants were included, and the frequency of rehabilitation sessions was determined at the discretion of the therapist based on each participant's condition. Each rehabilitation session was quantified and visualized using radar charts. Discussion: This study offers insight into the quantification and visualization of rehabilitation effects in patients with progressive neurodegenerative diseases presenting with parkinsonism. Future efforts should focus on accumulating data under standardized conditions and assessing motor symptoms longitudinally to develop personalized rehabilitation programs for patients with neurodegenerative disorders.

Indexed as

Corticobasal degenerationdigital biomarkerexercise therapyParkinson plus syndromeParkinson’s diseaseprogressive supranuclear palsyrehabilitationwearable device

Identifiers

PMID40771968
PMCPMC12325046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.